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Background: The current dietary recommendations for cardiovascular disease (CVD) risk 
reduction include increased fruit and vegetable consumption. The Opuntia spp., Prickly Pear 
(PP) fruit is rich in dietary fiber and may have lipid-lowering effects but it is often confused 
with the PP stem/leaf (Cladode (CLD)), or not identified. The efficacy of the PP fruit and CLD 
in reducing CVD risk is a growing area of research. 
Methods: This systematic review (PROSPERO: CRD42018110643), examined the effects of 
consuming the Opuntia spp. components (PP or CLD) on CVD risk factors, specifically total 
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein 
cholesterol (HDL-C) and triglycerides (TG). The review, performed from February through 
September 2019, used resources available through Food Science and Technology Abstracts 
(EBSCO), Medline, Scopus, CINAHL, Web of Science and Cochrane databases. 
Results and Discussion: Eleven articles met the inclusion criteria, which characterised 
Opuntia spp. products as either PP (n=6), CLD (n=5) or commercial products’ (n=1). Effects 
were investigated in healthy and obese populations as well as those with metabolic illnesses, 
specifically type 2 diabetes and metabolic syndrome. PP consumption was associated with 
 
 
significant reductions in TC (p<0.05) in all but one included study, whereas in the remaining 
studies (n=6), LDL-C levels decreased (p<0.05). Separately, the effect of CLD consumption 
on lipids was small with one study reporting a significant increase in plasma HDL-C in a 
subgroup of participants (>45 years of age) following consumption of a patented CLD powder 
product. It is plausible, that differences in overall effect may be due to compositional 
distinctions between CLD and PP, such as fiber composition. Care must be taken in future 
studies to accurately report the identity of the selected components of Opuntia spp. 
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Circulating lipoproteins are often monitored in CVD risk management due to their frequent 
accumulation and associated risk of atherosclerotic plaques [1]. Lipoproteins differ in size, 
density (high or low) and composition (i.e. cholesterol incorporation), and so do their 
association with CVD risk [1]. High-density lipoproteins (HDL) are reported to have anti- 
atherogenic effects, whereas low-density lipoproteins (LDL), are considered an atherogenic 
risk due to their affinity for cholesterol incorporation and resultant deposits, the atherosclerotic 
plaques, on blood vessel walls [1]. Within the class of LDL particles, are different LDL 
subclasses or sizes, and resultantly differ in associated effect with CVD risk [1]. Smaller LDL 
particles are reported to be associated with an increased CVD risk due their extended (blood) 
circulation life, increased susceptibility to modifications such as oxidation, or higher affinity 
for LDL receptors on foam cells [1]. 
Consensus exists in that of the lipoproteins, predominantly modified LDL (through oxidation, 
desialylation or glycation) contribute to the formation of the atherosclerotic plaques [1]. It is 
proposed that the modification of LDL, through oxidation for example, occurs when there is a 
high level of circulating free radicals within the circulatory system – a condition commonly 
seen in oxidative stress [1]. Oxidative stress is believed a result of mitochondrial dysfunction, 
pollution, poor diet and excessive alcohol consumption and smoking [2]. 
Emerging evidence supports the modifying effects of specific foods, nutrients or compounds 
on CVD risk, such as lipid-lowering effects, and indicates the importance of promoting ‘fruit 
 
 
and vegetable-rich’ diets [3]. The lipid-lowering effects associated with fruit and vegetable 
consumption is often associated with changes to cholesterol regulation through either altered 
dietary fat absorption, increased secretion, altered receptor activity or reductions in oxidation 
(modification) of LDL [4]. For example, fruits and vegetables that are considered to have a 
substantial dietary fiber content are often associated with lipid-lowering effects low-density 
lipoprotein-cholesterol (LDL-C) levels as an independent risk factor of CVD [5, 6]. More 
specifically, consumption of water-soluble dietary fibers such as β-glucan, psyllium, pectin and 
guar gum are associated with an increase in bile acids in stool samples, up-regulation of LDL 
receptors and increased liver activity, resulting in reduced serum cholesterol and LDL 
concentrations [6]. 
 
Previous studies on the health effects of specific foods cover a range of conditions such as 
familial hypocholesterolemia [7]; induced post-prandial dyslipidemia [8]; or metabolic syndrome 
(MetS) [9]. The use of such nutritional aids over pharmaceutical interventions are often advised 
as the first line of treatment due to the lower associated costs and the potential of reduced side- 
effects. Research related to the health benefits of specific foods and their associations with 
positive health outcomes is becoming more prominent, particularly in the areas of food 
supplements, functional foods (modified or fortified food products with health benefits) and 
nutraceuticals (whole food with beneficial health effects based on a particular content, e.g. 
phytochemical content) [10, 11]. However, immediate use of dietary aids over pharmaceuticals is 
not yet implementable due to necessity for more research and the current variations between 
regulatory bodies globally [11]. 
Some popular foods investigated for reduced risk of CVD include probiotics [11], red yeast rice 
[10], fish oils [11] and plant-based materials such as soya bean [10], Berberis aristata root [10], and 
the fruit of interest, the Prickly Pear (PP) [12, 13]. Such foods are rich in phytochemicals [10], 
phytosterols [10], soluble dietary fibers [10] and are proposedly associated with CVD risk 
reduction in aspects of blood pressure [14], body weight [14] and cholesterol-lowering effects [14]. 
Foods rich in polyphenols, a key bioactive group, are reportedly protective against CVD due 
to their antioxidant or anti-inflammatory properties or their role in nitric oxide production [15]. 
The Opuntia spp. cacti components of PP and cladode (cactus pad; CLD) have been used in 
traditional medicines of the Central and North Americas [16-18]. The PP is considered favourable 
based on its palatability along with its high fiber, particularly pectin, high mineral and 
phytochemical  content  [19].  The  consumption of PP  is  reported to  lower  the  risk  of some 
 
 
atherosclerotic pathologies [7, 16-18, 20] and their potentially beneficial effects (PP and CLD) are 
often confused with one another, or used interchangeably within the literature [19, 21] in spite of 
being considerably different in their composition and proposed effects upon consumption [7, 16- 
19, 22]. This systematic review aims to examine the current evidence on the effects of the 
consumption of Opuntia spp. cacti components (PP and CLD) on blood lipids in human and 
help clarify some of the issues. 
 
 
2. Materials and Methods 
 
This review was registered with the international register of systematic reviews, PROSPERO 
(CRD42018110643). The searches were performed following the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 2009 (PRISMA) statement [23]. The literature 
searches were conducted in six electronic databases: Food Science and Technology Abstracts 
(EBSCO), Medline, Scopus, CINAHL, Web of Science, and Cochrane databases using specific 
free-word search terms detailed in Section 2.1. Database outputs and reference lists were 
screened for relevance by title, abstracts and full text (Figure 1). 
Figure 1. PRISMA Flow chart of database output exclusion. 
 
2.1 Search Terminology and Selection Criteria 
 
The following search terminology was used to produce the database outputs: “(Opuntia OR 
“Prickly Pear" OR "Cactus Fruit" OR “Tuna Fruit” OR "Indian Fig" OR Cladode OR Stems 
OR Nopal OR “Cactus pad” OR “Cactus Stem” OR “Cactus Leaf”) AND (Dyslipid*mia OR 
Hyperlipid*mia OR Hypercholesterol*mia OR ‘Cholesterol’ OR ‘HDL’ OR ‘LDL’ OR 
‘Triglycerides’)”. The results were limited to (included on the basis of) quantitative, human, 
intervention control-trials investigating the effects of Opuntia spp. fruit or stem/leaf 
consumption on blood/serum lipids in humans, since journal inception until September 2019. 
Additionally, the included results were limited to original peer-reviewed full-text articles 
published in English. The included articles’ reference lists were also searched for any 
additional relevant studies. 
The exclusion criteria included: 1) participants were out of the 18-65 years age range, 2) 
research not conducted in humans, or 3) research was observational or did not contain a control, 
4) involved the consumption of a different cactus species (not Opuntia spp.), or 5) included the 
 
 
consumption of other cactus products (not fruit or leaf or their commercial products), or 6) the 
consumed components were unidentified, or 7) the publication type was one of conference 
proceedings, abstracts, opinion papers, editorials, guidelines, commentaries, case reports, or 
various forms of review articles. 
 
 
2.2. Data Extraction and Outcomes of Interest 
 
Two reviewers (C. A. G and R. M) independently screened titles and abstracts of the search 
results for their relevance. Any disagreements were resolved via discussion. The data extraction 
from the included articles was undertaken by C. G. and RM. EndNote® citations software (v8, 
Clarivate Analytics) was used in the process. 
 
2.3. Data Analysis 
 
The included studies were evaluated using the ‘Cochrane Risk of Bias Tool’ [24] and compared 
by statistically significant differences by means, defined by the initial article analysis (p<0.05 
or p<0.001). The forms of bias considered included; selection, performance, detection, 
attribution, reporting and ‘other’ biases, scored either ‘low’, ‘high’ or ‘unclear’ and are defined 
within the tool [25]. 
3. Results 
 
3.1. Literature Search 
 
The search strategy produced 5003 references (Figure 1) for consideration. After removal of 
duplicates (n=786), 4217 references were screened for relevance by title and then by the 
abstract. A total of 17 articles were relevant when considering only the titles and abstracts. 
However, only 11 articles [7, 26-36] met the inclusion criteria. The four studies excluded on 
different grounds are identified in Figure 1. Out of the 11 included articles, six investigated the 
PP fruit (Table 1) [26-30, 37], four, the CLD (Table 2) [31-35] and one, used formulated Opuntia 
spp. products (Table 3) [36]. The included studies did not feature mixed PP fruit and CLD 
products or ‘unspecified’ products. 
 
 
Table 1. Summary of the effects of Opuntia spp. fruit consumption on blood lipids in 
human trials [7, 26-30]. 
Table 2. Summary of the effects of Opuntia spp. Cladode consumption on blood lipids in 
human trials [31-35]. 
Table 3. Summary of the effects of Opuntia spp. fruit and Cladode product consumption 
on blood lipids in human trials [36]. 
 
 
3.2 Risk of Bias 
 
Using the Cochrane Risk of Bias Tool [24], the included studies were scored for bias by C. A. 
G. and R. M. Investigations into Opuntia spp. components (Table 4), shared unclear or 
unreported selection, performance and detection bias. Overall attribution and reporting biases 
were generally categorised as ‘low’. Studies including the ‘high’ bias ratings were mainly 
orientated towards the; “selection bias”, typically a result of health condition screening [28, 29, 
31], “performance bias” due to of blinding such as ‘un-blinded’ or ‘un-matched’ treatments [26, 
30, 32, 36], and lastly recognition of selective reporting [30]. 
Table 4. Risk of bias summary information for studies included in this systematic 
review [7, 26-36]. 
 
3.3 The effect of Opuntia spp. cactus product consumption 
 
3.3.1 Results of the effect of Opuntia spp. Prickly Pear Fruit consumption 
 
The included studies investigating the effects of PP consumption (Table 1) shared similar 
dietary interventions but varied in length of intake (2-8 weeks), population characteristics; 
gender (Male: n=83; Female: n=26) and health status (‘healthy’, hyperlipidemic, familial 
heterozygous hypercholesterolemia, metabolic syndrome (MetS), and Type II Diabetes). The 
included studies [7, 27, 28] used different PP fruit preparations; PP flesh (250 g) as a dietary fiber 
replacement (50 %; w/w) of a prescribed and standardized diet [7, 27, 28]; PP juice (150 ml) [26] 
and lastly, fruit peel (250 g) [30]. 
The use of PP, as a fiber substitute, was investigated in a study by Budinsky et al. (2001) [7] in 
males (n=8) and females (n=7) with heterozygous hypercholesterolemia, and later, in similar 
studies by Wolfram et al. (2002) [28] and Palumbo et al. (2003) [27]. The results of the study by 
 
 
Budinsky et al. (2001) [37] indicated a significant increase in total cholesterol (TC; p=0.02; 
293.3±22.4 to 299.1±27.0 ) in the intervention group following four weeks of PP consumption 
(despite that, the authors reported, in the text, a significant decrease in total cholesterol levels). 
The levels of LDL-C went down significantly in the treatment group (p=0.04; 223.0±23.6 to 
208.0±20.3). No significant changes in High-density lipoprotein cholesterol (HDL-C; p>0.05) 
or triglycerides (TG) levels (p>0.05) were seen [7]. Palumbo et al.’s (2003) [27] initial findings 
were also replicated by Wolfram et al. (2002) [28] in a parallel control trial with a longer 
intervention period in i) hypercholesterolemic and ii) hyperlipidemic populations for TC (i. 
and ii.; p<0.005), LDL-C (i. and ii.; p<0.005) and HDL-C (ii. p<0.01) [28]. Again, no effect 
was reported in HDL-C (i. p>0.05) and TG (i. and ii.; p>0.05) [28]. Following a similar study 
design, Palumbo et al. (2003) also included the consumption of PP based on dietary fiber 
supplementation (50 %; w/w) following a similar duration (4 weeks) in participants with 
familial isolated hypercholesterolemia. The findings of this study reported significant 
reductions in groups; i) males, ii) females and iii) all participants, in; TC (iii. p<0.0001; i. 
p<0.0014) and LDL-C (iii. p<0.001; i. p<0.0022; ii. p<0.0001) [27]. Furthermore, the control 
measures (‘regular diet’ vs. ‘treatment’) were again found to alter comparisons, in that it also 
had a reducing effect, on the following measures; LDL-C (ii. p=0.0001; iii. p=0.0001) and 
HDL-C (iii. p=0.0026) [27]. 
A separate intervention also considered the effect of PP pulp using a similar study design to 
that of Wolfram et al. (2002) [28] and Palumbo et al. (2003) [27], where treatment was replaced 
with an isocaloric diet, rather than a fiber replacement [29]. The intervention reported significant 
reductions in TC (p=0.04) and LDL-C (p=0.03) in both males and females with heterozygous 
hypercholesterolemia after eight weeks of a controlled diet, followed by four weeks of PP pulp 
(250 g/ day) consumption [29]. 
Investigating the effect of a separate component, and associated waste product of the PP, 
Pimienta-Barrios et al. (2008) [30] considered the effects of PP peel consumption on blood lipids 
in healthy males undergoing an Oral Glucose Tolerance Test (OGTT). The study found 
significant reductions in TC at 60 and 180 minutes (p<0.05), in healthy males with OGTT 
induced hyperglycemia, but not other time intervals. No effect was reported on TG (p>0.05), 
and lipoproteins were not investigated [30]. 
Another study investigated the consumption associated effects of PP, as a juice, in ‘healthy’ 
males (n=22) in addition to an exercise intervention (yo-yo intermittent recovery test; parallel) 
[26]. The consumption of PP juice was reported to reduce serum TC, TG and LDL-C (All 
 
 
p’s<0.05) after the consumption of juice but not HDL-C (p>0.05) for comparisons; i) between 
control and treatment, post-exercise; and ii) before and after consumption [26]. 
3.3.2 Results of the effect of Opuntia spp. Cladode consumption 
 
Studies which examined CLD consumption on blood lipids (Table 2), administered the 
treatment as boiled vegetable [31, 32] or capsules [33]. In a study by Frati-Munari et al. the broiled 
CLD (100 g; 3 x day before meals) was tested in three populations; ‘healthy’ (n=8), obese 
(n=14) and T2DM participants (n=7) [31]. In this study, when compared to a ‘normal diet’ 
(control; 10 days; parallel design), significant reductions were reported in ‘healthy’ populations 
for TC (p<0.01), and in both i) obese and ii) T2DM for; TC (i. p<0.001; ii. p<0.05), LDL-C (i. 
p<0.001; ii. p<0.05) and TG (ii. p<0.05). A study by Pignotti et al. (2016) also considered the 
effects of CLD (boiled) consumption using cucumber as a control [32]. The findings of this study 
reported that in the hypercholesterolemic group (n=16), there were no significant differences 
between the CLD and cucumber consumption for TC (p=0.440), HDL-C (p=0.687), LDL-C 
(p=0.341) and TG (p=0.09) between the CLD and cucumber consumption [32]. 
Although there was no reported effect of CLD consumption on blood lipids overall, Pignotti et 
al. (2016) did report changes in cholesterol content of lipoproteins (LDL and HDL) after 
consumption [32]. In addition cholesterol content of large HDL, significant reductions in 
cholesterol incorporation were measured in large LDL (p=0.037) but not in small LDL [32]. 
This may indicate that CLD consumption may reduce CVD risk [32, 38]. 
In a placebo-controlled monocentric double-blind, randomized control trial, 68 female 
participants diagnosed with metabolic syndrome, with a body mass index (BMI) between 25 
and 40 kg/m2, were randomly allocated into two groups and the intervention groups received a 
patented fiber powder (made from dried CLD) for 42 days (1.6 g powder/meal in capsules) 
with the other group receiving placebo capsules [35]. The study reported an average increase of 
0.0217 g/L (HDL-C; no p-value provided) in the intervention group while this increase was 
significant in the over 45 years of age subgroup (0.049 g/L; p=0.029) of the intervention group. 
In addition, the latter subgroup indicated a measurable but not significant decrease in serum 
TG level of 154 g/L (p = 0.103) [35]. 
A study by Linarés et al. (2007) used the commercially available ‘NeOpuntia©’ capsules (3 x 
1.6 g/day; dehydrated CLD) in females with MetS (n=59) [33]. In this population sample, 
supplementation was found to have no effect on TC (p=0.156), LDL-C (p=0.673), HDL-C 
(p=0.090) or  TG (p=0.388) at 14 days. At 42 days there were no differences in TC (p=0.429), 
 
 
LDL-C (p=0.256), HDL-C (p=0.082) and TG (p=0.435) [33]. However, the participants 
consuming placebo capsule (contents not reported) exhibited significant reductions in TC 
(p=0.041) at 14 days, and TC (p=0.035) and LDL-C (p=0.05) at 42 days [33]. 
3.3.3 Results of the effect of Opuntia spp. fruit and cladode product consumption 
 
Only one of the included studies in this systematic literature review investigated the effects of 
both PP and CLD on the lipid responses in healthy participants (Table 3) [36]. The Opuntia spp. 
cactus products were formulated as either bar-snacks or tortillas to examine the consumption 
associated effect on blood lipids, in ‘healthy’ participants (n=28) over three weeks [36]. The 
effects of consumption were studied as fortified or unfortified bars (PP jam) or tortillas (CLD). 
The observed results indicated significant differences in TC (p<0.05), LDL-C (p<0.05) and TG 
(p<0.05) between placebo and treatment (CLD) tortillas; where the only difference between 
treatment bars containing PP jam and corresponding placebo bar-snacks was found in LDL-C 
(p<0.05) [36]. The effect of both active treatments (PP and CLD) together was not investigated. 
4. Discussion 
 
The hypolipidemic actions associated with fruit and vegetable consumption have consistently 
been proposed due to fiber content [5] and associations with altered rates of fat absorption, in 
addition to its phytochemical composition, reducing oxidative stress [15], amongst other 
mechanisms [6, 7, 26-34, 36]. 
 
4.1. Opuntia spp. fruit 
 
Studies reporting the effects of PP consumption indicate that PP consumption (PP flesh, peel 
and juice) can cause significant reductions in TC in hyperlipidemic populations [7, 27, 28] (Tables 
1 and 3). Khouloud et al. (2018) reported significant decreases in TC, TG and LDL-C in 
‘healthy’ males after two weeks of juice supplementation (150 ml per day), after exercise post- 
exercise (yo-yo intermittent recovery test), although such results were unclear, as significant 
increases were reported in the controls [26]. An overall reduction in LDL-C was observed in all 
included studies investigating the PP (pulp, juice and bar) in ‘healthy’ and hyperlipidemic 
participants [7, 26-28]. Additionally, in one of the included studies, there was a significant 
reduction in HDL-C in participants with heterozygous hypercholesterolemia with participants 
that did not follow a controlled diet within the ‘pre-running’ or ‘lead-in’ period [27]. 
Furthermore, in two studies the TC levels increased in the control groups potentially due to the 
 
 
introduced ‘control diets’ [26, 28]. Overall, it could be seen that the consumption of PP products 
might suppress the rise of lipid measures through factors such as inhibiting fat absorption, 
rather factors inducing lipid-lowering effects. 
The consistent reduction in TC and LDL-C is suggestive of an effect via one or more of the 
cholesterol regulatory pathways, such as modulation of dietary fat absorption, increase in bile 
secretion or up-regulation of LDL receptor activity (LDL-R) [4]. The modulation relationship 
is regulated by factors including the rate of very-low-density lipoprotein (VLDL)/LDL 
conversion, LDL-C production and transport rate [4]. The PP fruit’s lipid-lowering effects have 
been proposed to be a result of its high fiber content resulting in the altered rate of absorption 
that perhaps interrupts the entero-hepatic circulation of lipids [7, 27, 28]. The reductions in TC 
and LDL-C in the included articles [27, 28, 37] investigating the effect via dietary supplementation 
with PP (fiber replacement), maybe due to the PPs high pectin content [7, 27, 28]. 
Pectin consumption is associated with an increase in fecal bile acid and up-regulation of LDL- 
R via promotion of chenodeoxycholic (bile) acid synthesis, and hepatic uptake resulting in 
reduced serum cholesterol concentrations [6]. Similar studies [7, 27, 28] showing significant 
reductions in TC and LDL-C after consumption of PP are limited by unquantified dietary fiber 
or pectin composition in the diet of participants during i) baseline and ii) controlled diet. Within 
these investigations, bile acid clearance was also not reported. Based on the reviews findings, 
despite the limited number of studies available, the lipid-lowering effects of PP identifies its 
potential as a functional food ingredient that may assist in the reduction of CVD risk factors, 
due to its compositional characteristics with particular reference to fiber and phytochemical 
content [10]. 
4.2. Opuntia spp. Cladode (leaf) 
 
The included studies (Table 2 and 3) investigating CLD consumption, provided conflicting 
results concerning its efficacy in modifying blood lipid levels [31-33, 35]. Significant decreases 
were observed for TC in ‘healthy’, obese, T2DM participants simultaneously [9, 31]. One study 
[35] showed a significant increase in the average serum HDL levels for the age group of >45 
years, following 42 days consumption of a patented CLD powder (NeOpuntia®), with a smaller 
increase for the whole intervention group (p-value not reported). The remainder of the included 
studies in this group did not report any significant effects on the lipid profile (all p’s>0.05). 
The   variability   in   the   studies’   components   (treatment   and   control  groups,   types of 
 
 
interventions, and variation in design and intervention length) may also account for the 
conflicting results. 
Two studies included in this review reported no significant differences in blood lipid 
parameters between CLD and controls (cucumber [32] or placebo capsules [35]). The capsule- 
based studies were conducted on participants with MetS (all females) and were associated with 
contradicting results about the observed HDL-C level. In one of the studies [35], consumption 
of the control capsules resulted in significant reductions in TC which could be due to the 
combined effect of dietary changes in response to a ‘healthy balanced diet’ and changes in 
participants’ physical activity (minimum 30 minutes). When CLD was consumed as a 
vegetable (280 g; control: cucumber) over two weeks, there were no differences in blood lipid 
markers [32]. In another study, the consumption of CLD powder for 42 days caused significant 
increases in serum HDL levels with an insignificant decrease in the average serum TG level 
for the +45 year of age sub-group for the intervention group [35]. 
Therefore, the findings suggest that there is inconsistent evidence about the effect of Opuntia 
spp. CLD consumption on blood lipids. Future studies of CLD consumption as a potential lipid- 
lowering food product should consider the consumption of treatments at higher doses (>280 g 
per day) for more extended periods (>8 weeks) with cautions towards gastrointestinal 
discomfort when consuming fiber-rich foods. The potential for an effect at either higher dose 
or extended period is supported by similar investigations into CLD fiber powder consumption, 
finding significant increases in fat binding capacity, and an increase in fecal fat excretion 
(p<0.001) upon consumption of much smaller dose (500 mg) in ‘healthy’ humans [39]. Such 
effects are widely proposed to be the underlying mechanisms of bodyweight reduction 
provided by Opuntia spp. products [14]. 
5. Conclusions 
 
In conclusion, PP and CLD do not share equivalent hypolipidemic and hypocholesterolemic 
effects. The consumption of the PPs flesh as a fiber replacement consistently demonstrated a 
significant reduction in TC in hyperlipidemic participants. Similarly, PP consumption is 
reported to reduce LDL-C in ‘healthy’ and hyperlipidemic participants. The CLD did not share 
the same effects, possibly due to compositional variations. Nevertheless, the CLD, when 
consumed as a vegetable, did indicate the potential for a more substantial impact with an 
increased dose or served as a vegetable (>280 g) over a longer period in hyperlipidemic 
 
 
participants. Further research into the lipid-lowering properties of the PP should consider 
standardization of the fiber in the provided food products (study foods) to assist in determining 
the underlying mechanisms of action. Nonetheless, the PP appears to be a good source of 
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Table 1. Summary of the effects of Opuntia spp. Prickly Pear fruit consumption on blood lipids in human trials [7, 26-30]. 
 
Author (Year) Participants, Sample Size, Aim Intervention Outcomes Results (T vs C) 
 
Country Gender and Age.  
Khouloud et ‘Healthy’ Males (n=22) Effect of PP juice Duration: 2 weeks Pre vs. Post C: ↑ TC (p<0.01), TG 





CVD parameters and 
biochemical markers 
following a Yo-Yo 
intermittent recovery 
test 
T: 3 x 50 ml of PP juice/day; 
3,000 kcal diet 











(p<0.05), HDL-C (p<0.01) 
and LDL (p<0.01) 
T: ↓ TC (p<0.05), TG 
(p<0.05) and LDL-C 
(p<0.05) 
ND on HDL-C (p>0.05) 
Budinsky et 
al. (2001) [7] 
Austria 
Familial heterozygous isolated 
hypercholesterolemic 
participants (n=15) 
Male (n=8) Age: 35±6.3 yrs. 
 
Female (n=7) Age: 31.6±6.3 
yrs. 





Phase i: Baseline (4 weeks) 
 
Phase ii: Dietary counselling 
(4 weeks), 
Phase iii: T(PP) (4 weeks) 






Males vs Females: 
HDL-C (p=0.03). 
Phase i) vs. ii): 
 
Males and females: ND in 
TC (p>0.05), LDL-C 
 
 
T: Fiber replacement (625 kJ; 
50% of fiber replaced with 250 
g/day broiled) 
C: Dietary counselling (7506 
kJ diet) 
Parallel Control-trial 
TG (p>0.05) or HDL-C 
(p>0.05). 
Phase ii) vs iii): 
Males: 
↓ TC (p=0.01) and LDL-C 
(p=0.05). 
Females: ND on TC 
(p>0.05), LDL-C (p>0.05), 
HDL-C (p>0.05), TG 
(p>0.05). 
 
Phase i) vs iii): 
Males: 
↓ TC (p=0.04) and LDL-C 
(p=0.04). 






↓ TC (p=0.01) and LDL-C 
(p=0.04). 
ND on HDL-C (p>0.05) or 
TG (p>0.05). 







Male: (n=6) Age: 27-46 yrs. 
 
Female:  (n=4)  Age: 25-40 
yrs. 
Effect of PP on liver 





Duration: 4 weeks 
 
Phase i: Baseline (4 weeks) 
 
Phase ii: Dietary counselling 
(4 weeks), 
Phase iii: T(PP) (4 weeks) 
 
T: (625 kJ; 50% of fiber 
replaced with 250 g/day 
broiled) 
C: Dietary counselling (7506 
kJ diet) 
Parallel-Controlled trial 






Phase i) vs ii): 
 
ND on TC (p>0.01), LDL- 
C (p>0.01), HDL-C 
(p>0.01) overall, females or 
males. 
Phase ii) vs iii): 
 
↓ Overall TC (p<0.0001) 
LDL-C (p<0.001). 
↓Male TC (p<0.0014), 
LDL-C (p=0.0022). 
↓ Female LDL-C 
(p<0.0001). 




↓ Female LDL-C 
(P=0.0001). 
↓ Overall HDL-C 
(p<0.0026). 
Wolfram et 










Group B: Hyperlipidemia 
(n=12) 
Effect of PP pectin 
on blood glucose and 
lipids in 
hypercholesterolemi 
c and hyperlipidemic 
patients 
Duration: 8 weeks 
 
Dietary counselling (8 weeks), 
T(PP) (8 weeks) 
T: (625 kJ; 50% of fiber 
replaced with 250 g/day) 
C: Dietary counselling (7506 
kJ diet) 
Parallel-Controlled trial 







Group A vs B Baseline: 
 
↑ Group A in LDL-C 
(p<0.0001). 
↑ Group B in TG 
(p=0.0001). 
Phase     i)     vs    ii): 
Group A: ↓ TC (p<0.005), 
LDL-C (p<0.005) and 
HDL-C (p<0.01). 
ND on TG (p>0.01). 
 
Group B: ↓ TC (p<0.005), 
LDL-C (p<0.005). 









































Age: 42.4±3.3 yrs 
The effect of PP 
consumption on TC, 











The effects of yellow 




(Chronic; 5 weeks) 
Duration: 8 weeks 
 
Dietary counselling 
(8 weeks, once a week) 
T(PP): 250 g/day Opuntia 
lidheimerii       fruit        pulp 
(4 weeks) 






T: 250 g fruit peel and GLU 
solution 
C: 75 g GLU (solution) 
Control trial 
Phase 2: 
Duration: 5 weeks 












OGTT (12 hr. 
fasted) 
Time   -20,   0, 20, 
30,   60,   80,  100, 
120, 140, 160, 
190, 200 min 
 
 
Phase 1 and 2: 
TC 
TG 
T vs C: 
↓ TC (p=0.04) 
↓ LDL-C (p=0.03) 
 











↓TC: at 60 min and 180 min 
(p>0.05). ND on other time 
points. 
ND on TG (p<0.05). 
Phase 2: 









1 BMI: Body Mass Index; Yrs.: Years; PP: Prickly Pear; C: Control; T: Treatment; TC: Total Cholesterol; LDL-C: Low-Density Lipoprotein 
Cholesterol; HDL-C: High-Density Lipoprotein Cholesterol; TG: Triglycerides; GLU: Glucose; ND: No Difference; ↓: Decrease; ↑: Increase. 






Size, Gender and Age. 
Aim Intervention Outcomes Results (T vs C) 
 
Frati-Munari 





Males (n=11) and 
Females (n=18) 
Group 1: ‘Healthy’ 
(n=8) 
Group 2: Obese (n=14) 
Group 3: Diabetic (n=7) 
Effect of CLD 
consumption on 
blood lipids 
Duration: 10 days 
 
T: 100 g broiled CLD, before meals, 
3 x day 


















ND in LDL-C (p>0.05), HDL- 
C (p>0.05) and TG (p>0.05) 
Group 2: 
 
↓TC (p<0.001), LDL-C 
(p<0.001) and TG (p<0.001). 
 




↓TC (p<0.05), LDL-C 
(p<0.05) and TG (p<0.05). 
ND in HDL-C (p>0.05). 
 










Age: 46±14 yrs. 
BMI: 31.4±5.7 kg/m2 
Effects of CLD leaf 
on lipoprotein 
profiles  in 
hypercholesterolemi 
c adults. 
Duration: 2 weeks. 
 
2-3 weeks wash-out. 
 
T: 280 g CLD/day (Boiled) 
C: 266 g Cucumber/day 
Randomized Cross-over Controlled 
Trial 







T vs C: 
 
ND for TC (p=0.440), HDL-C 
(p=0.687), LDL-C (p=0.341) 




↓Cholesterol in large LDL-C 
(p=0.037) in T. 
ND Cholesterol in small LDL- 
C (p=0.573). 
ND in Cholesterol in small 
(p=0.455), intermediate 
 
(p=0.980) or large (p=0.481) 
HDL-C. 
 







Age: 20-55 yrs. 
BMI: 24-40 kg/m2 
Duration: 6 weeks 
 
T: 3 x 1.6 g NeOpuntia© 
(Dehydrated CLD leaf)/day 
C: Placebo capsule 
 
Randomized double-blind placebo- 
controlled trial 






Day 0 vs Day 14 
 
T: ND in TC (p=0.156), LDL- 
C (p=0.673), HDL-C 
(p=0.090) and TG (p=0.388). 
C: ↓TC (p=0.041). 
 
ND in LDL-C (p=0.060), 
HDL-C (p=0.346) and TG 
(p=0.767). 
Day 0 vs. Day 42 
 
T: ND in TC (p=0.429), LDL- 
C (p=0.256), HDL-C 
(p=0.082) and TG (p=0.435). 
C: ↓TC (p=0.035) and LDL-C 
(p=0.05). 






Females with MetS 
(n=68) 
Age: 47.3± 10.1 yrs 
BMI: 25-40 kg/m2 
The effects of a 
patented powder of 
leaves of Opuntia 
ficus-indica 
(NeOpuntia ®) on 
blood lipids 
Duration: 6 weeks 
Treatment: 1.6 g CLD powder/meal 
in capsules 
Control: Placebo capsule 
Both treatments: 2000 Kcal diet, 
limited lipid intake, no more than 30 
minutes exercise for both groups 
A monocentric placebo-controlled, 
randomized, double-blind trial 
Measurement of 
blood lipids on Day 





T vs. C 
↑ in HDL (Day 42; by 0.0217 
g/L; no p-value provided). 
 
T vs. C of subgroup (>45 yrs) 
↑ in HDL (Day 42; increase 
by 0.049 g/L; p = 0.029) 
ND in TG (decrease of 154 
g/L; p=0.103) 
1 MetS: Metabolic Syndrome; BMI: Body Mass Index; Yrs.: years; CLD: Cladode; C: Control; T: Treatment; TC: Total Cholesterol; LDL-C: Low- 












Size, Gender and 
Sample 
Age. 








To determine bio- 
functional effects 
Length: 3 weeks 
Treatment: Supplement d 
Fasted (8 hrs.) 
iet with 40 
blood samples 
T (PP pulp jam bars) vs. C: 









of nopal (CLD) 
and PP products 
g Bars: Control-bar vs ‘Nopal (32 %) 
with PP pulp Jam’ bar (15 g); and 
100 g Tortillas vs. Tortillas with 
Nopal (48 %). 






ND on TC, HDL, TG 
(p>0.05). 
T (Tortilla) vs C: 
↓ TC (p<0.05), LDL 
(p<0.05) and TG (p<0.05). 
ND on HDL (p>0.05) 
 
1 MetS: Metabolic Syndrome; BMI: Body Mass Index; Yrs.: years; CLD: Cladode; C: Control; T: Treatment; TC: Total Cholesterol; LDL-C: Low- 






Table 4. Risk of bias summary for included studies in this systematic review [7, 26-36]. 
 
Selection Bias Performance Bias Detection Bias Attrition Bias Reporting Bias Other 
Bias 
 







 outcome data reporting  
Prickly Pear fruit         
 
Budinsky et al. 
(200 
 















Unclear Unclear Unclear Unclear Low High Low 













am  et  al. High Unclear Unclear Unclear Low Low Low 
oud  et  al. Unclear Unclear High Unclear Low Low Low 
 
0) [29] 






















et al. (2011) [36] 
Unclear Unclear High Unclear Low Low Low 
 
 
1 The forms of bias considered included; selection, performance, detection, attribution, reporting and ‘other’ biases, scored either ‘low’, ‘high’ or 
‘unclear’. 
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